Repatriation of MV Hondius passengers from Canary Islands nears completion amid hantavirus outbreak
Three passengers have died while others remain ill as authorities manage the evacuation of 94 people affected by the rare outbreak
A complex, day-long operation to repatriate occupants of the cruise ship MV Hondius neared completion late Sunday following an outbreak of hantavirus in Spain's Canary Islands. The logistical effort involved flying 94 people of various nationalities home after the vessel was struck by a deadly disease that has left several passengers critically ill.
The repatriation process, described as intricate by officials managing the operation, concluded as the affected individuals were flown from the Canary Islands. This movement marks the culmination of a significant health and security response to the rare rodent-borne disease, which has no specific vaccine or treatment currently available to medical teams.
Three passengers from the MV Hondius have confirmed deaths as a result of the outbreak. The casualties include a Dutch couple and a German woman, while other passengers on the vessel remain ill. The severity of the situation has characterised the event as a deadly outbreak requiring urgent international coordination.
The origins of the outbreak are linked to the ship's itinerary, as the MV Hondius departed from Argentina in April. Hantavirus is endemic to Argentina, and the disease typically spreads among rodents, creating a specific epidemiological context for the incident aboard the cruise ship.
Medical consensus at the time of reporting indicates that no vaccines or specific treatments exist for hantavirus. This lack of a cure complicates the management of the remaining ill passengers, who continue to require monitoring and care following their evacuation from the Canary Islands.
The operation highlights the challenges posed by rare diseases in a maritime context, where rapid repatriation is essential for both public health and the well-being of the affected individuals. As the evacuation nears finalisation, the focus remains on the ongoing health status of those still recovering from the infection.
